B. Metzler seel. Sohn & Co. AG Boosts Stake in Colgate-Palmolive Company $CL

Key Points

• B. Metzler seel. Sohn & Co. AG increased its stake in Colgate-Palmolive Company by 10.1%, owning 435,008 shares valued at approximately $40.76 million.
• Several hedge funds significantly boosted their holdings in Colgate-Palmolive during the first quarter, with institutional investors now owning 80.41% of the company's stock.
• Colgate-Palmolive recently reported earnings of $0.92 per share, exceeding estimates, and announced a quarterly dividend of $0.52 per share, reflecting a yield of 2.5%.

B. Metzler seel. Sohn & Co. AG boosted its stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 10.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 435,008 shares of the company's stock after buying an additional 39,857 shares during the period. B. Metzler seel. Sohn & Co. AG owned 0.05% of Colgate-Palmolive worth $40,760,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of CL. Westend Capital Management LLC lifted its holdings in Colgate-Palmolive by 111.1% during the first quarter. Westend Capital Management LLC now owns 266 shares of the company's stock worth $25,000 after buying an additional 140 shares during the period. Cornerstone Planning Group LLC lifted its holdings in Colgate-Palmolive by 1,913.3% during the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock worth $28,000 after buying an additional 287 shares during the period. Vermillion Wealth Management Inc. purchased a new stake in Colgate-Palmolive during the fourth quarter worth $31,000. Accredited Wealth Management LLC acquired a new position in shares of Colgate-Palmolive during the fourth quarter worth $34,000. Finally, Bernard Wealth Management Corp. acquired a new position in shares of Colgate-Palmolive during the fourth quarter worth $36,000. Hedge funds and other institutional investors own 80.41% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Morgan Stanley reduced their price target on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Wells Fargo & Company reduced their price target on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a research report on Monday, August 4th. JPMorgan Chase & Co. reduced their price target on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. Finally, Barclays upped their price target on Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 15th. Seven investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $98.92.

Colgate-Palmolive Price Performance

Shares of CL opened at $84.21 on Wednesday. The firm has a market capitalization of $68.06 billion, a PE ratio of 23.66, a price-to-earnings-growth ratio of 4.37 and a beta of 0.35. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. Colgate-Palmolive Company has a 1-year low of $82.40 and a 1-year high of $109.30. The company's fifty day moving average price is $87.39 and its 200-day moving average price is $89.90.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. The firm had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business's quarterly revenue was up 1.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.91 earnings per share. On average, equities research analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were given a dividend of $0.52 per share. The ex-dividend date was Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. Colgate-Palmolive's payout ratio is currently 58.43%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.